.

Deeper Knowledge, Faster

  • Find suppliers and generic API sources
  • Uncover prior art in expired and abandoned patents
  • Set up watchlists for daily email updates

► See Plans & Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving 500+ biopharmaceutical companies globally:

Johnson and Johnson
Merck
UBS
Mallinckrodt
Baxter
Deloitte
Argus Health
Accenture
Healthtrust
Cipla

Generated: July 22, 2017

DrugPatentWatch Database Preview

CORTRIL Drug Profile

« Back to Dashboard

What is the patent landscape for Cortril, and what generic Cortril alternatives are available?

Cortril is a drug marketed by Pfizer, Pfizer Global, and Pfipharmecs. and is included in four NDAs.

The generic ingredient in CORTRIL is hydrocortisone acetate. There are sixty drug master file entries for this compound. Three suppliers are listed for this compound. Additional details are available on the hydrocortisone acetate profile page.

Summary for Tradename: CORTRIL

Patents:0
Applicants:3
NDAs:4
Bulk Api Vendors: see list55
Clinical Trials: see list4
Patent Applications: see list4,234
Formulation / Manufacturing:see details
Drug Prices:see details
DailyMed Link:CORTRIL at DailyMed
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Pfizer
CORTRIL
hydrocortisone
TABLET;ORAL009127-005Approved Prior to Jan 1, 1982DISCNNoNo► Subscribe► Subscribe
Pfizer Global
CORTRIL
hydrocortisone
OINTMENT;TOPICAL009176-001Approved Prior to Jan 1, 1982DISCNNoNo► Subscribe► Subscribe
Pfizer
CORTRIL
hydrocortisone
TABLET;ORAL009127-003Approved Prior to Jan 1, 1982DISCNNoNo► Subscribe► Subscribe
Pfizer
CORTRIL
hydrocortisone acetate
INJECTABLE;INJECTION009164-001Approved Prior to Jan 1, 1982DISCNNoNo► Subscribe► Subscribe
Pfipharmecs
CORTRIL
hydrocortisone
TABLET;VAGINAL009796-001Approved Prior to Jan 1, 1982DISCNNoNo► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving 500+ biopharmaceutical companies globally:

Novartis
Cerilliant
QuintilesIMS
Deloitte
Teva
UBS
Fish and Richardson
McKesson
Harvard Business School
Cipla

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted Heap | Mobile and Web Analytics

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot